{"id":688623,"date":"2022-09-26T07:15:26","date_gmt":"2022-09-26T11:15:26","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/c4-therapeutics-to-present-at-bank-of-america-securities-precision-oncology-conference-2022\/"},"modified":"2022-09-26T07:15:26","modified_gmt":"2022-09-26T11:15:26","slug":"c4-therapeutics-to-present-at-bank-of-america-securities-precision-oncology-conference-2022","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/c4-therapeutics-to-present-at-bank-of-america-securities-precision-oncology-conference-2022\/","title":{"rendered":"C4 Therapeutics to Present at Bank of America Securities Precision Oncology Conference 2022"},"content":{"rendered":"<div class=\"mw_release\">\n<p>WATERTOWN, Mass., Sept.  26, 2022  (GLOBE NEWSWIRE) &#8212; C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation science to develop a new generation of small-molecule medicines and transform how disease is treated, today\u00a0announced that C4T management will participate in a fireside chat at the virtual Bank of America Securities Precision Oncology Conference 2022.<\/p>\n<p>\n        <strong>Presentation Details:<\/strong><br \/>\n        <br \/>Event: Bank of America Securities Precision Oncology Conference 2022<br \/>Date\/Time: Monday, October 3<sup>rd<\/sup>, 2022 at 9:50 a.m. ET<\/p>\n<p>A live webcast of the presentation will be available on the Investors section of the company\u2019s website at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=rL5c4WTyRnlAmfWyGR1tpw65_lbOOTvzK6bZVmSdU0eADwbtMmq_3D4dNP8GnZ9A47uo18Vd7XiXcAwDIfslrzuKdNhCLhENS0hfPvz87ak=\" rel=\"nofollow noopener\" target=\"_blank\">www.c4therapeutics.com<\/a>. An archived replay of the webcast will be available for approximately 30 days following the presentation.<\/p>\n<p>\n        <strong>About C4 Therapeutics<\/strong><br \/>\n        <br \/>C4 Therapeutics (C4T) (Nasdaq: CCCC) is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients\u2019 lives. C4T is leveraging its TORPEDO<sup>\u00ae<\/sup>\u00a0platform to efficiently design and optimize small-molecule medicines that harness the body\u2019s natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, drug undruggable targets and improve patient outcomes. C4T is advancing multiple targeted oncology programs to the clinic and expanding its research platform to deliver the next wave of medicines for difficult-to-treat diseases. For more information, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=rL5c4WTyRnlAmfWyGR1tpw65_lbOOTvzK6bZVmSdU0el6VOxEQGe1gChzNixFu6AUNVgoeiMdJTWFDW5pRJ3y5qXI0Z28TRQomTPfU_UJtM=\" rel=\"nofollow noopener\" target=\"_blank\">www.c4therapeutics.com<\/a>.<\/p>\n<p>\n        <strong>Investor Contact:<\/strong>\u00a0<br \/>Courtney Solberg\u00a0<br \/>Senior Manager, Investor Relations\u00a0<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=MiEYWf9U9a9k10BvGwocI_vAq6sPn6m-O2sYAv7Z5f_i4jDiaw5pFm4mFzI5QBHOEjMZ8XeUtREjlMQwmmcssTZS6uVF9wkHmUkg3sGx_FGFMKS7YSErydOgiv1XTNEt\" rel=\"nofollow noopener\" target=\"_blank\">CSolberg@c4therapeutics.com<\/a><\/p>\n<p>\n        <strong>Media Contact:<\/strong>\u00a0<br \/>Loraine Spreen\u00a0<br \/>Director, Corporate Communications &amp; Patient Advocacy<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=PR6xO6GyiZ1UiRp8uDyLCsC9XGL0xwong59_YLBpE3IDyjU-L-0rP7WCEXraWJIsrID-hKqQncqk1gjFKDVhwE76fEEkmCn_ViUM8MtphcXJ_4GqWHgqweOHpUXodaCQ\" rel=\"nofollow noopener\" target=\"_blank\">LSpreen@c4therapeutics.com<\/a><\/p>\n<p \/>\n      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY1MTk5OCM1MTY4MDUxIzIyMDAzODc=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/ODlkMWQ1MTctZDYwNC00MGRhLWI3YzYtNzJiZTY1ZjZjNjM2LTEyMTE5NDA=\/tiny\/C4-Therapeutics-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>WATERTOWN, Mass., Sept. 26, 2022 (GLOBE NEWSWIRE) &#8212; C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation science to develop a new generation of small-molecule medicines and transform how disease is treated, today\u00a0announced that C4T management will participate in a fireside chat at the virtual Bank of America Securities Precision Oncology Conference 2022. Presentation Details: Event: Bank of America Securities Precision Oncology Conference 2022Date\/Time: Monday, October 3rd, 2022 at 9:50 a.m. ET A live webcast of the presentation will be available on the Investors section of the company\u2019s website at\u00a0www.c4therapeutics.com. An archived replay of the webcast will be available for approximately 30 days following the presentation. About C4 Therapeutics C4 Therapeutics (C4T) (Nasdaq: &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/c4-therapeutics-to-present-at-bank-of-america-securities-precision-oncology-conference-2022\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;C4 Therapeutics to Present at Bank of America Securities Precision Oncology Conference 2022&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-688623","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>C4 Therapeutics to Present at Bank of America Securities Precision Oncology Conference 2022 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/c4-therapeutics-to-present-at-bank-of-america-securities-precision-oncology-conference-2022\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"C4 Therapeutics to Present at Bank of America Securities Precision Oncology Conference 2022 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"WATERTOWN, Mass., Sept. 26, 2022 (GLOBE NEWSWIRE) &#8212; C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation science to develop a new generation of small-molecule medicines and transform how disease is treated, today\u00a0announced that C4T management will participate in a fireside chat at the virtual Bank of America Securities Precision Oncology Conference 2022. Presentation Details: Event: Bank of America Securities Precision Oncology Conference 2022Date\/Time: Monday, October 3rd, 2022 at 9:50 a.m. ET A live webcast of the presentation will be available on the Investors section of the company\u2019s website at\u00a0www.c4therapeutics.com. An archived replay of the webcast will be available for approximately 30 days following the presentation. About C4 Therapeutics C4 Therapeutics (C4T) (Nasdaq: &hellip; Continue reading &quot;C4 Therapeutics to Present at Bank of America Securities Precision Oncology Conference 2022&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/c4-therapeutics-to-present-at-bank-of-america-securities-precision-oncology-conference-2022\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2022-09-26T11:15:26+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY1MTk5OCM1MTY4MDUxIzIyMDAzODc=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/c4-therapeutics-to-present-at-bank-of-america-securities-precision-oncology-conference-2022\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/c4-therapeutics-to-present-at-bank-of-america-securities-precision-oncology-conference-2022\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"C4 Therapeutics to Present at Bank of America Securities Precision Oncology Conference 2022\",\"datePublished\":\"2022-09-26T11:15:26+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/c4-therapeutics-to-present-at-bank-of-america-securities-precision-oncology-conference-2022\\\/\"},\"wordCount\":268,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/c4-therapeutics-to-present-at-bank-of-america-securities-precision-oncology-conference-2022\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODY1MTk5OCM1MTY4MDUxIzIyMDAzODc=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/c4-therapeutics-to-present-at-bank-of-america-securities-precision-oncology-conference-2022\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/c4-therapeutics-to-present-at-bank-of-america-securities-precision-oncology-conference-2022\\\/\",\"name\":\"C4 Therapeutics to Present at Bank of America Securities Precision Oncology Conference 2022 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/c4-therapeutics-to-present-at-bank-of-america-securities-precision-oncology-conference-2022\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/c4-therapeutics-to-present-at-bank-of-america-securities-precision-oncology-conference-2022\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODY1MTk5OCM1MTY4MDUxIzIyMDAzODc=\",\"datePublished\":\"2022-09-26T11:15:26+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/c4-therapeutics-to-present-at-bank-of-america-securities-precision-oncology-conference-2022\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/c4-therapeutics-to-present-at-bank-of-america-securities-precision-oncology-conference-2022\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/c4-therapeutics-to-present-at-bank-of-america-securities-precision-oncology-conference-2022\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODY1MTk5OCM1MTY4MDUxIzIyMDAzODc=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODY1MTk5OCM1MTY4MDUxIzIyMDAzODc=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/c4-therapeutics-to-present-at-bank-of-america-securities-precision-oncology-conference-2022\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"C4 Therapeutics to Present at Bank of America Securities Precision Oncology Conference 2022\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"C4 Therapeutics to Present at Bank of America Securities Precision Oncology Conference 2022 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/c4-therapeutics-to-present-at-bank-of-america-securities-precision-oncology-conference-2022\/","og_locale":"en_US","og_type":"article","og_title":"C4 Therapeutics to Present at Bank of America Securities Precision Oncology Conference 2022 - Market Newsdesk","og_description":"WATERTOWN, Mass., Sept. 26, 2022 (GLOBE NEWSWIRE) &#8212; C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation science to develop a new generation of small-molecule medicines and transform how disease is treated, today\u00a0announced that C4T management will participate in a fireside chat at the virtual Bank of America Securities Precision Oncology Conference 2022. Presentation Details: Event: Bank of America Securities Precision Oncology Conference 2022Date\/Time: Monday, October 3rd, 2022 at 9:50 a.m. ET A live webcast of the presentation will be available on the Investors section of the company\u2019s website at\u00a0www.c4therapeutics.com. An archived replay of the webcast will be available for approximately 30 days following the presentation. About C4 Therapeutics C4 Therapeutics (C4T) (Nasdaq: &hellip; Continue reading \"C4 Therapeutics to Present at Bank of America Securities Precision Oncology Conference 2022\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/c4-therapeutics-to-present-at-bank-of-america-securities-precision-oncology-conference-2022\/","og_site_name":"Market Newsdesk","article_published_time":"2022-09-26T11:15:26+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY1MTk5OCM1MTY4MDUxIzIyMDAzODc=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/c4-therapeutics-to-present-at-bank-of-america-securities-precision-oncology-conference-2022\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/c4-therapeutics-to-present-at-bank-of-america-securities-precision-oncology-conference-2022\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"C4 Therapeutics to Present at Bank of America Securities Precision Oncology Conference 2022","datePublished":"2022-09-26T11:15:26+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/c4-therapeutics-to-present-at-bank-of-america-securities-precision-oncology-conference-2022\/"},"wordCount":268,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/c4-therapeutics-to-present-at-bank-of-america-securities-precision-oncology-conference-2022\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY1MTk5OCM1MTY4MDUxIzIyMDAzODc=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/c4-therapeutics-to-present-at-bank-of-america-securities-precision-oncology-conference-2022\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/c4-therapeutics-to-present-at-bank-of-america-securities-precision-oncology-conference-2022\/","name":"C4 Therapeutics to Present at Bank of America Securities Precision Oncology Conference 2022 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/c4-therapeutics-to-present-at-bank-of-america-securities-precision-oncology-conference-2022\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/c4-therapeutics-to-present-at-bank-of-america-securities-precision-oncology-conference-2022\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY1MTk5OCM1MTY4MDUxIzIyMDAzODc=","datePublished":"2022-09-26T11:15:26+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/c4-therapeutics-to-present-at-bank-of-america-securities-precision-oncology-conference-2022\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/c4-therapeutics-to-present-at-bank-of-america-securities-precision-oncology-conference-2022\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/c4-therapeutics-to-present-at-bank-of-america-securities-precision-oncology-conference-2022\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY1MTk5OCM1MTY4MDUxIzIyMDAzODc=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY1MTk5OCM1MTY4MDUxIzIyMDAzODc="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/c4-therapeutics-to-present-at-bank-of-america-securities-precision-oncology-conference-2022\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"C4 Therapeutics to Present at Bank of America Securities Precision Oncology Conference 2022"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/688623","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=688623"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/688623\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=688623"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=688623"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=688623"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}